Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Globus Medical, Inc. (GMED) had Revenue of $2.52B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.52B
Net Income	$102.98M
Cost of Goods Sold	$1.04B
Gross Profit	$1.48B
Operating Expenses	$2.35B
Operating Income	$165.99M
Non-Operating Income/Expense	$-45.27M
Pre-Tax Income	$120.72M
Normalized Pre-Tax Income	$120.72M
Income after Taxes	$102.98M
Income from Continuous Operations	$102.98M
Consolidated Net Income/Loss	$102.98M
Normalized Income after Taxes	$102.98M
EBIT	$165.99M
EBITDA	$661.43M
Weighted-Average Shares Outstanding (Basic)	135.73M
Weighted-Average Shares Outstanding (Diluted)	137.86M
Earnings per Share (EPS) (Basic)	$0.76
Earnings per Share (EPS) (Diluted)	$0.75
Balance Sheet Financials
Current Assets	$2.18B
Property, Plant, and Equipment	$561.91M
Long-Term Assets	$3.07B
Total Assets	$5.25B
Current Liabilities	$855.91M
Long-Term Debt	--
Long-Term Liabilities	$218.50M
Total Liabilities	$1.07B
Common Equity	$4.18B
Tangible Shareholders Equity	$1.95B
Shareholders Equity	$4.18B
Common Shares Outstanding	137.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$520.64M
Cash Flow from Investing Activities	$-176.05M
Cash Flow from Financial Activities	$-27.70M
Beginning Cash	$467.29M
End Cash	$784.44M
Increase/Decrease in Cash	$317.15M
Stock-Based Compensation	$54.19M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.54
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	0.11
Gross Margin	58.90%
Operating Margin	6.59%
EBIT Margin	6.59%
EBITDA Margin	26.25%
Pre-Tax Profit Margin	4.79%
Profit Margin	4.09%
Free Cash Flow	$405.21M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.48
Inventory Turnover	1.57
Receiveable Turnover	4.36
Days Sales in Receivables	83.79
Return on Equity	2.47%
Return on Tangible Equity	5.28%
Return on Assets	1.96%
Return on Investments	2.47%
Book Value Per Share	$30.40
Free Cash Flow per Share	$2.94
Operating Cash Flow per Share	$3.78

Data from Zacks Investment Research, Inc.